Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

138results about How to "High purification yield" patented technology

Purification method of echinocandins antifungal drug anidulafungin

The invention discloses a purification method of echinocandins antifungal drug anidulafungi. The method comprises the following steps of: (1) preparing a dry sample: adding organic solvent in a crude product of the anidulafungin to dissolve the crude product, adding silica gel after the crude product of the anidulafungin is adequately dissolved, and uniformly mixing and drying the mixture to obtain the anidulafungin dry sample; (2) pressurizing and eluting: uniformly filling the anidulafungin dry samples in the top end of a chromatographic column with silica gel, pressurizing and eluting the chromatographic column with the anidulafungin dry samples by adding elution solvent, utilizing a high-effective liquid phase chromatography to monitor, and collecting the elution solution with the anidulafungin content being greater than 98 percent; and (3) concentrating: concentrating the elution solution with the anidulafungin content being greater than 98 percent until dryness to obtain a pure product with the anidulafungin content being greater than 98 percent. By adopting the column chromatography, simplicity in operation is realized, and the equipment cost is low; the organic solvent with low toxicity and low boiling point is adopted as the elution solution, so that the subsequent recycling treatment is simple, and the environmental pressure can be greatly reduced; and the purification separation time is short, the purification effect is good, the purification yield is high, and the purification method is applicable to industrialized mass production.
Owner:NCPC NEW DRUG RES & DEV

Preparation method of GLP (Glucagon-Like Peptide) -1 or analogue thereof and antibody Fc fragment fusion protein

The invention relates to the technical field of biology and particularly relates to a preparation method of a GLP (Glucagon-Like Peptide) -1 or analogues thereof and an antibody Fc fragment fusion protein. The preparation method of the GLP-1 or the analogues thereof and the antibody Fc fragment fusion protein comprises the following steps: cloning sequences for encoding the GLP-1 or the analogues thereof and the antibody Fc fragment fusion protein into an expression vector; transfecting the expression vector with CHO-DXB11 cells, culturing and screening a positive cell strain; expressing the obtained cell strain and purifying to obtain the fusion protein. By virtue of the preparation method provided by the invention, when the GLP-1-Fc molecule is expressed in DXB11 of the CHO cell line, the problem of degradation cannot be caused, the subsequent purification yield is greatly improved, the biological activity is not decreased and thus the preparation method is very suitable for the requirement of industrial production.
Owner:SYNDEGEN SHANGHAI BIOTECH

Recombinant human nerve growth factor purifying method based on CHO cell expression system

The invention relates to a recombinant human nerve growth factor purifying method based on a CHO cell expression system. The recombinant human nerve growth factor purifying method based on the CHO cell expression system comprises the following steps: 1), centrifugating supernatant, successively removing living cells and cell fragments, and removing impurities and bacteria by filtering; 2), applying a supernatant sample to an EMD SO3-(M) chromatography column, rinsing unbound protein and impure protein, eluting and collecting a target protein peak; 3), concentrating the protein with ultrafiltration equipment with a molecular weight cutoff of 3K; and 4), applying the sample to Superdex 75-containing chromatography column and collecting the target protein peak, namely a recombinant human nerve growth factor stoste. According to the CHO cell expression system and the recombinant human nerve growth factor purifying method based on the CHO cell expression system, the recombinant human nerve growth factor with the purity greater than 98% and the specific activity higher than the 5* 10 to the power of 5 AU / mg can be prepared; compared with other methods, the recombinant human nerve growth factor purifying method based on the CHO cell expression system has the advantages that the steps are reduced, the production cycle is greatly shortened, and the processing capacity and the yield are improved; therefore, the recombinant human nerve growth factor purifying method based on the CHO cell expression system is application for large-scale production.
Owner:北京福睿君安科技有限公司

Cetrorelix purification and separation method

The invention discloses a cetrorelix purification and separation method. The method includes steps: dissolving a crude product of cetrorelix in acetonitrile water solution, and filtering through a filter membrane to obtain crude solution for standby application; adopting a mobile phase A for balancing a reversed phase column, loading the crude solution into the reversed phase column, performing gradient eluting for separation and purification, wherein the mobile phase A refers to sodium dihydrogen phosphate aqueous solution, and a mobile phase B refers to acetonitrile; subjecting target peptide solution with purity higher than 99.5% to vacuum rotary evaporation and concentration at a water temperature not higher than 38 DEG C; adopting acetic acid aqueous solution for balancing the reversed phase column, loading a sample of concentrated liquid into the reversed phase column, and adopting an acetic acid aqueous solution/acetonitrile system for salt conversion; subjecting the converted acetate and the target peptide solution with purity higher than 99.5% to vacuum rotary evaporation and concentration at a water temperature not higher than 38 DEG C, and performing freeze drying to obtain powdery cetrorelix. The obtained cetrorelix is high in purity and yield, meets industrial production requirements and has a high economic value and a promising application prospect.
Owner:ZHEJIANG PEPTITES BIOTECH CO LTD

Acidic proteinase and preparation method thereof

InactiveCN101948820AIncrease profitHigh extraction and purification yieldHydrolasesMicroorganism based processesLeather industryAspergillus niger
The invention relates to an acidic proteinase and a preparation method thereof and the acidic proteinase belongs to the microbial acidic proteinase. The invention is characterized in that 1) the enzymatic characteristics of the acidic proteinase are as follows: the optimum pH value is 2.5-3.5, the stable pH value is 2.5-6.0; the optimum temperature is 40-50 DEG C, the temperature stability range is 30-50 DEG C; and 2) the preparation method uses Aspergillus Niger which is stored in the China Center of Industrial Culture Collection (CICC) and has a preservation number of 2238, as the enzyme-producing strain and uses wheat bran as the raw material; the solid fermentation technology is adopted for preparation; the fermentation and enzyme-producing capability is not less than 47000u / g (dry yeast), the liquid enzyme yield is not less than 85% and the soid enzyme yield is not less than 80%, which all achieve the food grade sanitation standard. The invention provides the acidic proteinase and the preparation method thereof, wherein the utilization rate of the fermentation equipment is high, the byproduct of crop processing is used as the main raw material, the enzyme activity for fermentation is high, the extracting and purifying rate of enzyme is high and the production cost is low. The acidic proteinase of the invention is suitable to be used as the raw material or product additive of the products in the leather industry, the pharmaceutical industry, the brewing industry and the feed industry.
Owner:SHANDONG LONGKETE ENZYME PREPARATION

Method for purifying methylal

The invention relates to a method for purifying methylal. The method comprises the following steps of: adding water into methylal of which the mass concentration is less than 95 percent and uniformly stirring, wherein the added water is 0.1-3 times the weight of the methylal; standing for 20-40 minutes for layering; adding a drying agent into an upper layer for drying, and stirring for 5-15 minutes, wherein the water sucking weight of the added drying agent is 1-12 times the wet weight of the methylal in the upper layer; and drying, and filtering the drying agent out to obtain the methylal of which the mass concentration is more than 99.5 percent, wherein the water-containing drying agent can be recycled by dehydrating. The method has the advantages: water is added into the methylal for extracting, and water is taken as an extracting agent, so that the cost is low, the purifying process is simple, the condition is mild, the purifying amount is large, industrial continuous production is facilitated, the mass concentration is stable and reliable, and other impurities are eliminated. The methylal is purified in a way of rectifying with a high-pressure rectifying system, so that the requirement on raw material quality is low, the purifying yield is high, the energy demand is low, industrial continuous production is facilitated, harmful substances are not discharged, and environmental protection is facilitated.
Owner:印海平

Technique for purifying recombined human interferon alpha 1b

A process for purifying recombinant human interferon alpha 16 includes such steps as breaking the engineered bacteria able to express human interferon alpha 16 in buffering Tris-HCl solution, adsorbing on expanding bed by use of anionic gel, buffering Tris-HCl solution and the eluting liquid containing NaCl and Tris-HCl, affinity chromatography by use of the gel coupled by its monoclonal antibody, PBS as balancing liquid and washing liquid, Gly-HCl as eluting liquid, Tris-HCl as regeneration liquid and NaAc-Hac as buffering liquid, and gel filtering by use of Sephacryl gel and PBS as buffering system.
Owner:SHENZHEN KEXING PHARMA CO LTD

CYP101 enzyme recombinant vector, construction method thereof and CYP101 enzyme high-efficiency expression and purification method

The invention relates to a CYP101 enzyme recombinant vector, a construction method thereof and a CYP101 enzyme high-efficiency expression and purification method, and belongs to the field of biotechnology. A PET28a-CYP101 high-efficiency expression vector is constructed and transformed into BL21 plysS strain, and high-purity enzyme with purity higher than 95% is obtained by a simple two-step purification method including affinity chromatography and ion exchange chromatography after inducible expression. Compared with the prior art, CYP101 is simply and efficiently produced, the cost is low, purification is facilitated, and 23mg of target protein with the purity higher than 95% can be obtained by per liter of culture media. The CYP101 enzyme high-efficiency expression and purification method can be used for expressing and purifying CYP101 enzyme, the production efficiency of a laboratory is greatly improved, and experimental cost is greatly reduced. The CYP101 enzyme high-efficiency expression and purification method has an excellent application prospect for large-scale CYP101 enzyme production and purification.
Owner:SHANGHAI JIAO TONG UNIV

Method for producing recombinant human bone morphogenetic protein-2 mature peptide

The invention relates to a method for producing recombinant human bone morphogenetic protein-2 mature peptide. The method comprises the following steps: sampling a recombinant human bone morphogenetic protein-2 mature peptide solution with good renaturation into a balanced hydrophobic chromatography column, then performing a stepped-gradient elution which gradually reduces the salinity by an elution buffer solution, and collecting target peaks. In order to further enhance the protein purity of the target peaks, the purification method can be a multi-step hydrophobic interaction chromatography or be used by combining with the ion exchange chromatography. The method has the advantages of simple operation, lower cost, higher purification yield (more than 20%), higher purity (SDS-PAGE, HPLC and HPCE are greater than 97%) and the like, and is suitable for producing the recombinant human bone morphogenetic protein family.
Owner:HANGZHOU JIUYUAN GENE ENG

Method for purifying L-valine from L-valine complex

The present invention relates to a method for purifying L-valine from a L-valine complex. The method comprises: A, complexing racemic DL-valine and a resolving agent N-benzoyl-L-alanine to obtain an L-valine complex, adding 0.5-5 times the organic solvent to the L-valine complex, and carrying out heating reflux for 1-3 h in a reaction kettle; B, filtering the mixture obtained in the step A while hot, returning the solid to the kettle, adding 0.5-5 times the organic solvent, carrying out stirring reflux for 1-3 h, repeatedly performing three times, and filtering to obtain an L-valine crude product; C, adding 10-20 times the water to the crude product obtained in the step B, carrying out heating dissolving, decolorizing with active carbon, and filtering to obtain a decolorizing liquid; and D, carrying out pressure reducing concentration crystallization on the decolorizing liquid obtained in the step C in a crystallization kettle, filtering, and drying the wet product to obtain the L-valine finished product. According to the present invention, the hetero amino acids are not generated, the purification yield is obviously improved, the finished product quality is improved, the decolorizing liquid separation with the adsorption column in the traditional purification method is eliminated, and the operation is simple.
Owner:HUANGGANG WELLMAN BIOSCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products